CONCEPTUS INC
			Symbol			CPTS

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Essure® to Be Highlighted at 18th Annual Congress of the European Society for Gynaecological Endoscopy

2009-10-29 04:00 ET - News Release

Company Website: http://www.conceptus.com
MOUNTAIN VIEW, Calif. -- (Business Wire)

Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure^® procedure, the first proven non-incisional permanent birth control method available, today announced that the clinical success of the Essure^®procedure will be highlighted at the 18^th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE) in Florence, Italy from October 28-31, 2009.

The Essure^®procedure now has 12 accepted abstracts at ESGE from presenters across Europe recognizing the procedure as the Gold Standard for hysteroscopic sterilization. Among these is an oral presentation by Dr. T. Justin Clark, MRCOG, of the Birmingham Women’s Hospital. On October 30 he will be presenting his abstract entitled, “Essure^® Permanent Birth Control: Worldwide Experience 2000 to 2009.” The abstract will focus on the clinical efficacy of Essure^®, zero pregnancies in clinical studies and the 94.6% bilateral placement rate of the device.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.